Pfizer [PFIZER] vs Sanofi India Limited [SANOFI] Detailed Stock Comparison

Pfizer Ltd.

NSE
Loading...

Sanofi India Limited

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Pfizer Ltd. wins in 12 metrics, Sanofi India Limited wins in 8 metrics, with 0 ties. Pfizer Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Pfizer Ltd. Sanofi India Limited Better
P/E Ratio (TTM) 25.56 24.31 Sanofi India Limited
Price-to-Book Ratio 5.66 10.59 Pfizer Ltd.
Debt-to-Equity Ratio 2.33 2.38 Pfizer Ltd.
PEG Ratio 2.28 -0.97 Pfizer Ltd.
EV/EBITDA 22.48 16.08 Sanofi India Limited
Profit Margin (TTM) 34.39% 17.78% Pfizer Ltd.
Operating Margin (TTM) 33.17% 19.32% Pfizer Ltd.
EBITDA Margin (TTM) 33.17% 19.32% Pfizer Ltd.
Return on Equity 18.20% 40.59% Sanofi India Limited
Return on Assets (TTM) 15.63% 19.81% Sanofi India Limited
Free Cash Flow (TTM) $6.32B $4.13B Pfizer Ltd.
Dividend Yield 1.27% 4.60% Sanofi India Limited
1-Year Return -23.35% -49.23% Pfizer Ltd.
Price-to-Sales Ratio (TTM) 8.78 4.32 Sanofi India Limited
Enterprise Value $194.17B $78.16B Pfizer Ltd.
EV/Revenue Ratio 7.82 4.25 Sanofi India Limited
Gross Profit Margin (TTM) 65.15% 50.43% Pfizer Ltd.
Revenue per Share (TTM) $543 $798 Sanofi India Limited
Earnings per Share (Diluted) $186.40 $141.75 Pfizer Ltd.
Beta (Stock Volatility) 0.17 0.18 Pfizer Ltd.

Pfizer Ltd. vs Sanofi India Limited Stock Performance Analysis

Loading Price Chart...

PFIZER
SANOFI

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Pfizer Ltd.0.20%-0.22%-8.81%-4.87%-9.94%-8.09%
Sanofi India Limited3.84%2.46%0.71%-5.74%-22.80%-20.92%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Pfizer Ltd.-23.35%16.94%-16.55%139.64%232.33%479.18%
Sanofi India Limited-49.23%-54.97%-58.99%-25.65%55.45%103.00%

Performance & Financial Health Analysis: Pfizer Ltd. vs Sanofi India Limited

MetricPFIZERSANOFI
Market Information
Market Cap i₹218.82B₹79.35B
Market Cap CategoryLarge capMid cap
10 Day Avg. Volume i14,47046,430
90 Day Avg. Volume i18,45036,764
Last Close₹4,518.00₹3,240.70
52 Week Range₹4,396.70 - ₹5,993.00₹3,054.00 - ₹6,410.00
% from 52W High-24.61%-49.44%
All-Time High₹6,451.15 (Sep 02, 2024)₹10,524.95 (Jun 10, 2024)
% from All-Time High-29.97%-69.21%
Growth Metrics
Quarterly Revenue Growth0.20%-0.19%
Quarterly Earnings Growth0.11%-0.33%
Financial Health
Profit Margin (TTM) i0.34%0.18%
Operating Margin (TTM) i0.33%0.19%
Return on Equity (TTM) i0.18%0.41%
Debt to Equity (MRQ) i2.332.38
Cash & Liquidity
Book Value per Share (MRQ)₹841.24₹325.31
Cash per Share (MRQ)₹591.12₹114.15
Operating Cash Flow (TTM) i₹9.08B₹4.38B
Levered Free Cash Flow (TTM) i₹7.68B₹3.58B
Dividends
Last 12-Month Dividend Yield i1.27%4.60%
Last 12-Month Dividend i₹70.00₹192.00

Valuation & Enterprise Metrics Analysis: Pfizer Ltd. vs Sanofi India Limited

MetricPFIZER (Apr 24, 2026)SANOFI (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i25.5624.31
Forward P/E i25.1519.43
PEG Ratio i2.28-0.97
Price to Sales (TTM) i8.784.32
Price to Book (MRQ) i5.6610.59
Market Capitalization
Market Capitalization i₹218.82B₹79.35B
Enterprise Value i₹194.17B₹78.16B
Enterprise Value Metrics
Enterprise to Revenue i7.824.25
Enterprise to EBITDA i22.4816.08
Risk & Other Metrics
Beta i0.170.18
Book Value per Share (MRQ) i₹841.24₹325.31

Financial Statements Comparison: Pfizer Ltd. vs Sanofi India Limited

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricPFIZER (2025)SANOFI (2025)
Revenue/Sales i22.81B18.23B
Cost of Goods Sold i8.13B9.06B
COGS % of Revenue i35.6%49.7%
Gross Profit i14.68B9.18B
Gross Margin i64.4%50.3%
Research & Development iN/AN/A
Operating Income (EBIT) i6.81B4.54B
Operating Margin i29.9%24.9%
EBITDA i9.13B5.10B
EBITDA Margin i40.0%28.0%
Pre-Tax Income i10.16B4.45B
Pre-Tax Income % of Revenue i44.5%24.4%
Income Tax i2.48B1.18B
Income Tax % of Revenue i10.9%6.5%
Net Income (Profit) i7.68B3.27B
Profit Margin i33.7%17.9%

Balance Sheet & Liquidity Metrics

MetricPFIZER (2025)SANOFI (2025)
Cash & Equivalents i4.95B2.63B
Total Current Assets i35.13B8.01B
Total Current Assets % of Revenue i154.0%43.9%
Total Current Liabilities i5.70B4.91B
Total Current Liabilities % of Revenue i25.0%26.9%
Long-Term Debt i676.20M137.00M
Long-Term Debt % of Revenue i3.0%0.8%
Total Shareholders Equity i42.17B7.49B
Retained Earnings i24.36B3.32B
Retained Earnings % of Revenue i106.8%18.2%
Property, Plant & Equipment i1.72B3.03B

Cash Flow Statement Comparison

MetricPFIZER (2025)SANOFI (2025)
Operating Cash Flow i9.08B7.22B
Operating Cash Flow % of Revenue i39.8%39.6%
Capital Expenditures i1.24B-253.00M
Free Cash Flow i6.32B4.13B
FCF Margin i27.7%22.6%
Debt Repayment iN/AN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricPFIZERSANOFI
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i45.75M23.03M
Float Shares i15.10M9.07M
% Held by Insiders i66.98%60.61%
% Held by Institutions i16.80%24.40%
% Held by Public i16.22%14.99%

Dividend Analysis & Yield Comparison: Pfizer Ltd. vs Sanofi India Limited

MetricPFIZERSANOFI
Last 12-Month Dividend i₹70.00₹192.00
Last 12-Month Dividend Yield i1.27%4.60%
3-Year Avg Annual Dividend i₹46.67₹245.33
3-Year Avg Dividend Yield i0.58%2.49%
3-Year Total Dividends i₹140.00₹736.00
Ex-Dividend DateJul 09, 2025Nov 07, 2025